Ipilimumab and Imatinib Mesylate in Advanced Cancer
Phase 1
Completed
- Conditions
- Metastatic Gastrointestinal Stromal TumorMetastatic MelanomaPathologic Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Solid NeoplasmUnresectable Solid NeoplasmAdvanced Malignant Solid NeoplasmUnresectable MelanomaC-KIT Tyrosine Kinase Protein Overexpression
- Interventions
- Biological: Ipilimumab
- First Posted Date
- 2012-11-30
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 68
- Registration Number
- NCT01738139
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Early Phase 1
Completed
- Conditions
- Brain TumorMalignant Neoplasm of Fourth Ventricle of Brain
- Interventions
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2018-01-19
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT01737671
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
πΊπΈChildren's Memorial Hermann Hospital, Houston, Texas, United States
PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer
Not Applicable
Active, not recruiting
- Conditions
- Malignant Mixed Mesodermal (Mullerian) TumorGrade 3 Endometrial Endometrioid AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed AdenocarcinomaEndometrial Serous Adenocarcinoma
- Interventions
- Procedure: Computed TomographyOther: Laboratory Biomarker AnalysisProcedure: Lymph Node MappingProcedure: LymphadenectomyProcedure: Positron Emission Tomography
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT01737619
- Locations
- πΊπΈ
MD Anderson Regional Care Center-The Woodlands, The Woodlands, Texas, United States
πΊπΈMD Anderson Regional Care Center-Sugar Land, Sugar Land, Texas, United States
πΊπΈThe Woman's Hospital of Texas, Houston, Texas, United States
Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas
Phase 2
Completed
- Conditions
- Colorectal CancerCancer of Gastrointestinal Tract
- Interventions
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT01730586
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma
Phase 2
Completed
- Conditions
- Plasma Cell LeukemiaPlasma Cell Myeloma
- Interventions
- Procedure: Autologous Hematopoietic Stem Cell TransplantationOther: Laboratory Biomarker AnalysisBiological: Umbilical Cord Blood-Derived Lymphocyte Therapy
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 72
- Registration Number
- NCT01729091
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
The Collection and Storage of Umbilical Cord Blood for Transplantation
Recruiting
- Conditions
- Hematopoietic Stem Cell TransplantationCord Blood TransplantationCord Blood Stem Cell Transplantation
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2019-05-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 250000
- Registration Number
- NCT01728545
- Locations
- πΊπΈ
MD Anderson Cord Blood Bank Collection Sites, Houston, Texas, United States
Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT01729104
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer
Phase 2
Completed
- Conditions
- Recurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
- Interventions
- Radiation: External Beam Radiation TherapyOther: Clinical ObservationOther: Laboratory Biomarker AnalysisOther: Quality-of-Life AssessmentProcedure: Therapeutic Conventional SurgeryProcedure: Standard Follow-Up Care
- First Posted Date
- 2012-11-12
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 85
- Registration Number
- NCT01725165
- Locations
- πΊπΈ
University of Colorado, Denver, Colorado, United States
πΊπΈM D Anderson Cancer Center, Houston, Texas, United States
π¨π¦London Health Sciences Centre-South Street, London, Ontario, Canada
Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk
- First Posted Date
- 2012-11-02
- Last Posted Date
- 2020-12-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 113
- Registration Number
- NCT01720225
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 2
Completed
- Conditions
- Plasma Cell MyelomaHematopoietic Cell Transplantation Recipient
- Interventions
- First Posted Date
- 2012-10-31
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 64
- Registration Number
- NCT01718743
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States